Paroxetine Hydrochloride
규격
78246-49-8CAS 번호
616-601-1EC 번호
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochlorideIUPAC 명칭
C19H21ClFNO3화학식
365.8 g/mol분자량
Paroxetine hydrochloride; 78246-49-8; Paroxetine Hcl; Paroxat; Paxil CR; 3I3T11UD2S; Paroxetine hydrochloride [USP]; Paroxetine Hydrochloride Anhydrous; NSC-758654; BRL29060A; CHEBI:7944; Paroxetine hydrochloride (USP); DTXSID50228914; Deroxat; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S,4R)-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-; Paxilcr CR; RefChem:858692; DTXCID00151405; (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine Hydrochloride; X2ELS050D8; Seroxat; Paxil; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride; paroxetine (hydrochloride); C19H21ClFNO3; MFCD00797405; 5V22ESA4MA; Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetine hydrochloride, (+/-)-; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride (1:1), (3S,4R)-; Paroxetine hydrochloride, trans-(+/-)-; Paxil (TN); (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride; Aropax 20; CHEMBL1708; MFCD03658863; 130855-16-2; (3S,4R)-3-[(Benzo[d][1,3]dioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride; BRL 29060 hydrochloride; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, trans-; trans-(+/-)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride (1:1), (3R,4S)-rel-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)-rel-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, trans-(+/-)-; BRL 29060A; SDB 7175; UNII-3I3T11UD2S; S3005; UNII-5V22ESA4MA; Paroxetine Impurity Standard; SCHEMBL33348; (-)-Paroxetine hydrochloride; Paroxetine HCl (hemihydrate); MLS002222322; SPECTRUM1504085; orb1224008; orb1307940; SCHEMBL29437926; HY-B0492R; GLXC-04133; HMS1922B11; Pharmakon1600-01504085; (-)-trans-paroxetine hydrochloride; HY-B0492; MSK10675; Tox21_500095; CCG-39866; EBC-12122; HB0478; NSC758654; AKOS015849162; AKOS015907108; Paroxetine (hydrochloride) (Standard); FP38223; FP60426; KS-5097; LP00095; NSC 758654; (3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Paroxetine hydrochloride [EP monograph]; NCGC00093597-01; NCGC00260780-01; Paroxetine hydrochloride (anhydrous) CRS; PAROXETINE HYDROCHLORIDE [WHO-DD]; BP164263; PAROXETINE HYDROCHLORIDE, ANHYDROUS; SMR001307264; SY105826; EU-0100095; P1977; SW197457-4; T1636; D05374; D70630; EN300-124073; Paroxetine HCl hemihydrate - Bio-X trade mark; PAROXETINE HYDROCHLORIDE ANHYDROUS [MI]; SR-01000759305; SR-01000759305-6; Q27257245; Z1557492145; (-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-piperidine hydrochloride; (-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-piperidine hydrochloride; (-)-trans-4-(4-fluorophenyl)-3-(3,4-methylene dioxyphenoxymethyl)-piperidine hydrochloride; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; (3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine hydrochloride; (3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride; (3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride Hemihydrate; (3S,4R)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine--hydrogen chloride (1/1); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-, hydrochloride (1:1); Anhydrous Paroxetine Hydrochloride; Paroxetine HCl anhydrous동의어
Paroxetine Hydrochloride 함유 제품
산도스파록세틴정(무수염산파록세틴)PAROXETINA VIR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TEVA-RATIO 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TEVA-RATIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TEVA-RATIO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGPAROXETINA PENSA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA MABO 40 mg COMPRIMIDOSPAROXETINA MABO 30 mg COMPRIMIDOSPAROXETINA MABO 20 mg COMPRIMIDOS EFGPAROXETINA MABO 10 mg COMPRIMIDOS EFG
1/5 페이지
Paroxetine Hydrochloride 판매 기업
삼일
삼일제약(주)Republic of KoreaSI
Sinoway Industrial Co.Ltd.China1/3 페이지